Stay updated on PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.

Latest updates to the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe revision label on the page has been updated from v3.5.3 to v3.5.4, indicating a software revision applied to the page.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page’s footer revision/version was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a maintenance/update to the ClinicalTrials.gov page software rather than a change to the trial details.SummaryDifference0.1%

- Check41 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page; no changes to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check106 days agoChange DetectedRevision: v3.4.2 is now displayed, replacing Revision: v3.4.1.SummaryDifference0.1%

Stay in the know with updates to PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.